CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
ISCT Meeting
ISCT Meeting 2022 May 4-7, 2022 StemExpress is excited to attend the ISCT Meeting, May 4-7, 2022, where we will join the leaders in cell and gene therapy to discuss the future of clinical research. As more commercial therapies are moving to approval stages, the need for clinical-level partners to support these projects is at an all-time high. Visit our booth to learn about the ways StemExpress can assist clients through the process of bringing therapies from the research and development phase…
Read More
ISSCR Annual Meeting 2022
April 15-18, 2022 San Francisco, CA StemExpress is excited to attend the ISSCR Annual Meeting, April 15-18, 2022, where we will discuss process acceleration in the development of life-saving therapies, from R&D to clinical commercialization. With vast expertise in the pre-clinical, clinical, and healthcare space, StemExpress knows the importance of moving projects through commercialization to then ensure scalability within the healthcare realm. Visit our booth to learn about the ways StemExpress can assist clients through each step in the therapy and drug…
Read More
AARC Annual Meeting 2022
March 11, 2022 (NEW ORLEANS, LA) – StemExpress is excited to attend the AACR Annual Meeting, April 8-13, 2022, where we will join the innovative minds in the clinical space to discuss the importance of picking partners from product development to clinical commercialization. As more cancer therapies move through clinical approval, our company mission is to help bring them to market faster and reduce the cost in the process. Visit us at booth 3941 to learn about how a partnership with StemExpress…
Read More
CEO & Founder Cate Dyer Discusses Cell & Gene Therapies with the Video Journal of Regenerative Medicine
Cate’s discussion focused on the importance of creating a closed-loop system for cell and gene clinical therapies by leveraging existing partnerships with hospital systems and the 8 U.S.-based StemExpress clinical collection centers within nearby proximity to industry-leading hospital systems.
Read More
Together For Science: CGT Global and Lonerider Brewery Team Up To Host Blood Donor Drives
StemExpress and Lonerider Brewery have teamed up to host blood donor drives on the 12th and 26th of March with a special twist – the event will give members of the community an opportunity to take part in life-saving medical research while enjoying the many handcrafted beers Lonerider has on tap, on us! Join us as we educate new donors on the scientific benefits of their blood or bone marrow donations and offer incentives for participation in the donor screening process.
Read More
2022 Advanced Therapies Week Audiogram
Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week. Picking the Right Partner from Product and Process Development Through Commercialization Qualifying how you choose your raw and starting material provider Increase your commercialization success rates through standardized methods, access to a diverse and recallable donor pool, and reduce outcome…
Read More
Biocom California Member Spotlight
Biocom California recently sat down with Cate Dyer, CEO & Founder of StemExpress to hear what it took to bring her vision to life and how the company built an end-to-end COVID-19 testing solution in a matter of weeks from the very beginning of the pandemic. The article discusses (1) the roots of StemExpress, (2) Cate’s vision for the future of the industry and the role of StemExpress in supporting this future, (3) the importance of building a culture in your company;…
Read More
Los Rios Colleges Partner with CGT Global to Provide COVID-19 Testing Sites on Campus
The Los Rios colleges, including American River, Cosumnes River, Folsom Lake and Sacramento City colleges, have partnered with biomedical company StemExpress to provide COVID-19 testing sites for employees, athletes, students and the community at each of the college campuses. Employers can also use these sites as they begin to bring back their workforce. In most cases, there are no out of pocket testing costs for the individual. “We understand the important role these academic institutions have on our community. Some of…
Read More
CGT Global Opens Facility In Northern Nevada
RENO, Nev., April 5, 2021 /PRNewswire/ — StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada. The property development will include a state-of-the-art cell collection center as well as a large-scale warehouse that contains a centralized shipping location for the company. The site will also be a new center for excellence training facility as well as include contract research and clinical services. This expansion will enable StemExpress to accelerate the advancement of research, clinical and…
Read More
Sacramento Kings Partner with CGT Global for COVID-19 Testing
“We are proud to partner with the Sacramento Kings in their COVID-19 testing for all games, keeping the players safe, healthy and on the court”
Read More